ofloxacin has been researched along with Bronchiolitis in 3 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Bronchiolitis: Inflammation of the BRONCHIOLES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously reported that a 6-month low-dose course of ofloxacin combined with long-term low-dose erythromycin therapy (EM therapy) was superior to EM therapy alone for sinobronchial syndrome (SBS), especially during the initial 2 months of treatment." | 9.10 | Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome. ( Fujimura, M; Mizuguchi, M; Mizuhashi, K; Nakatsumi, Y; Sasaki, S; Yasui, M, 2002) |
| "To ascertain the long-term effects of ofloxacin (OFX) on clinical parameters in cases of diffuse panbronchiolitis (DPB), we treated 18 patients with this disease with OFX and compared the clinical findings before and after treatment." | 9.07 | Long-term effects of ofloxacin on clinical courses in patients with diffuse panbronchiolitis. ( Chida, K; Iwata, M; Okano, A; Sato, A; Shichi, I; Suda, T, 1991) |
| "We previously reported that a 6-month low-dose course of ofloxacin combined with long-term low-dose erythromycin therapy (EM therapy) was superior to EM therapy alone for sinobronchial syndrome (SBS), especially during the initial 2 months of treatment." | 5.10 | Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome. ( Fujimura, M; Mizuguchi, M; Mizuhashi, K; Nakatsumi, Y; Sasaki, S; Yasui, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katsuki, Y | 1 |
| Motoishi, M | 1 |
| Tsutiya, M | 1 |
| Enokibori, T | 1 |
| Ninomiya, K | 1 |
| Fujimura, M | 1 |
| Mizuguchi, M | 1 |
| Nakatsumi, Y | 1 |
| Mizuhashi, K | 1 |
| Sasaki, S | 1 |
| Yasui, M | 1 |
| Sato, A | 1 |
| Shichi, I | 1 |
| Iwata, M | 1 |
| Suda, T | 1 |
| Okano, A | 1 |
| Chida, K | 1 |
2 trials available for ofloxacin and Bronchiolitis
| Article | Year |
|---|---|
Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bronchiolitis; Bronchitis; Drug Therapy, Combina | 2002 |
Long-term effects of ofloxacin on clinical courses in patients with diffuse panbronchiolitis.
Topics: Bronchiolitis; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ofloxacin; Res | 1991 |
1 other study available for ofloxacin and Bronchiolitis
| Article | Year |
|---|---|
[Pulmonary nocardiosis in a patient with diffuse panbronchiolitis].
Topics: Bronchiolitis; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Male; Middle Aged; Nocardia | 2009 |